UA Frame EN

Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Terka  (Anonymous, 5.173.164.) Polska 7 months ago

Should I continue to use Enbrelif the injection sites are red and itchy, and my whole body itches?

I have redness on my abdomen after the injection in 2 places that itch. And my skin itches all over my body. Should I continue to take injections?

1 answer

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Suggested Products

Space for your product

Your product would fit here?

Set up a sponsored products campaign yourself:

Check

Katarzyna Chadryś Pharmacist, Editor

7 months ago

According to the Enbrel manufacturer's information, a common side effect of this drug is itching. In the case of injection site reactions, they usually occurred within the first month of treatment and were transient - the average duration was about 3-5 days. Since the reaction to the drug is generalized and itching occurs not only at the injection sites, you should immediately consult your doctor about the observed ailments. He will decide on further proceedings.

Here you can take advantage of the teleconsultation:

https://www.gdziepolek.pl/telekonsultacja

What's more, adverse drug reactions should be reported not only to a doctor, but also to an individual. We wrote about how to do it here:

https://www.gdziepolek.pl/artykuly/jak-i-dlaczego-zglaszac-dzialania-niepozadane

I encourage you to read:

https://www.gdziepolek.pl/artykuly/czy-bac-sie-dzialan-niepozadanych-lekow

https://www.gdziepolek.pl/artykuly/reumatoidalne-zapalenie-stawow-rzs

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists